ArticleCancer cell2018

MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.

Lingtao Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.